Assessment of Visual and Refractive Results and Rotational Stability of the TECNIS® Eyhance Toric II 1-piece Posterior Chamber Lens in Patients With Astigmatism Undergoing Cataract Surgery

Overview

Cataract surgery is one of the most common procedures performed worldwide. Astigmatism is the most common refractive disorder in adults, hence there is a high prevalence of preexisting astigmatism in cataract patients. Access to astigmatism correction during cataract surgery allows for improved visual outcomes for patients. Toric intraocular lenses (IOLs) are the procedure of choice to correct corneal astigmatism of one diopter or more in cases undergoing cataract surgery. Rotational stability is a key factor for successful outcomes with toric IOLs. Postoperative toric IOL misalignment is the major factor responsible for suboptimal visual outcomes after toric IOL implantation. The TECNIS® Eyhance Toric II 1-piece posterior chamber lens is a new toric IOL which is FDA approved and CE marked. Marketed by Johnson & Johnson Vision, it is indicated for the visual correction of aphakia and pre-existing corneal astigmatism of one diopter or greater in adult patients with or without presbyopia in whom a cataractous lens has been removed by phacoemulsification and who desire reduction in residual refractive cylinder. No study assessing the early rotational stability of the TECNIS® Eyhance Toric II IOL has been published yet.

Full Title of Study: “Assessment of Visual and Refractive Results, and Rotational Stability of the TECNIS® Eyhance Toric II 1-piece Posterior Chamber Lens in Patients With Astigmatism Undergoing Cataract Surgery: a Prospective Cohort Study – STATE”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: April 2023

Interventions

  • Procedure: Images of the operated eye (s)
    • Through the operating microscope or a slit lamp, dilated pupil. Taken on the day of surgery (D0) and at 1 week, 1 month and 3 months post-op

Arms, Groups and Cohorts

  • Experimental: Patients operated with a TECNIS® Eyhance Toric II 1-piece posterior chamber lens
    • For at least one eye : Planned cataract surgery with placement of a TECNIS® Eyhance Toric II 1-piece posterior chamber lens

Clinical Trial Outcome Measures

Primary Measures

  • The mean of the best monocular uncorrected distance visual acuity UDVA (logMAR) at 1 month post-operative
    • Time Frame: 1 month
  • The mean of the best monocular corrected distance visual acuity (CDVA) (logMAR) preoperative (maximum 12 months before surgery)
    • Time Frame: 12 months

Participating in This Clinical Trial

Inclusion criteria

  • Aged ≥ 18 years – Patients scheduled for bilateral cataract surgery – For at least one eye : – Cataract surgery clinically indicated – Corneal astigmatism ≥ 1 D – Planned cataract surgery with placement of a TECNIS® Eyhance Toric II 1-piece posterior chamber lens Non inclusion criteria – Pregnant or breast-feeding women – In the eye with planned cataract surgery with placement of a TECNIS® Eyhance Toric II 1-piece posterior chamber lens: – Irregular astigmatism (keratoconus suspicion) – Corneal scaring in visual axis – Retinal impairment that may limit visual recovery (macular degeneration, history of retinal detachment, etc.) – Visually impaired eye since childhood that cannot be improved despite correction of the refractive disorder – Any other ophthalmic disease inducing visual impairment

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Fondation Ophtalmologique Adolphe de Rothschild
  • Collaborator
    • Johnson & Johnson
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Jean-Luc FEBBRARO, MD, Principal Investigator, Hôpital Fondation A. de Rothschild
  • Overall Contact(s)
    • Amélie YAVCHITZ, MD, +33148036433, ayavchitz@for.paris

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.